ABSTRACT
Smoking is a chronic disease, and it is considered a global epidemic associated with adverse effects on general and oral health. There is evidence that smoking cessation can improve health-related aspects and benefit the outcomes of dental treatments. Thus, it is important that dentists encourage smokers to stop smoking and provide care to those who wish to quit smoking. There are effective strategies that can be used by dental professionals to help smokers to quit and, consequently, obtain more favorable outcomes in the dental treatment. The aim of this literature review is to discuss the effect of smoking cessation on general and oral health, and to describe effective strategies to combat this important public health problem. Dentists should encourage their patients to quit smoking and they have an important role in this. There are many strategies available for health professionals to assist smokers that are willing to quit. (AU)
O tabagismo é uma doença crônica, considerada uma epidemia global, que leva à desfechos adversos na saúde geral e bucal. Por outro lado, há evidências de que a cessação desse hábito pode melhorar aspectos relacionados a saúde como um todo e beneficiar resultados de tratamentos odontológicos. Dessa forma, é fundamental que o cirurgião dentista motive fumantes a pararem de fumar e forneça assistência àqueles que desejam abandonar esse hábito. Para isso, existem estratégias eficazes que podem ser utilizadas para ajudar fumantes nessa difícil missão e, consequentemente, obter resultados mais favoráveis nos tratamentos realizados no consultório odontológico. O objetivo desta revisão de literatura foi discutir os efeitos da cessação do tabagismo sobre a saúde geral e bucal, bem como descrever estratégias eficazes para combater esse importante problema de saúde pública. Cirurgiões dentistas devem estimular seus pacientes a pararem de fumar e possuem um papel fundamental nessa questão. As estratégias disponíveis para assistir esses pacientes a parar de fumar podem e devem ser utilizadas por profissionais de saúde bucal. (AU)
Subject(s)
Nicotiana , Tobacco Use Cessation , NicotineABSTRACT
INTRODUCTION@#Cigarette smoking is a leading cause of morbidity and mortality, and has a deleterious effect on dermatological conditions, such as skin cancers, hidradenitis suppurativa and psoriasis. The study aimed to evaluate the efficacy of a pharmacist-led smoking cessation clinic in reducing cigarette smoking at a tertiary referral dermatology centre. We described the impact of this clinic to provide guidance on how such a model could be further improved and implemented more widely.@*METHODS@#In this single-centre, retrospective study, 74 currently smoking patients who received counselling at a structured smoking cessation clinic between January 2010 and March 2013 were identified. Information on baseline demographic characteristics and detailed past medical history, including smoking history, was collected. Follow-up was conducted at two weeks and three months.@*RESULTS@#At the first follow-up at two weeks, which was attended by 57 patients, 9 (15.8%) had stopped smoking and 26 (45.6%) showed reduction in the number of cigarette sticks smoked per day, with an average reduction of 4.1 cigarette sticks per day. However, a few patients also reported no change or increased number of cigarette sticks smoked per day following counselling.@*CONCLUSION@#A structured pharmacist-led smoking cessation clinic is effective and can be made a part of the holistic management of dermatological conditions.
Subject(s)
Adolescent , Adult , Female , Humans , Male , Middle Aged , Young Adult , Dermatology , Hidradenitis Suppurativa , Program Development , Psoriasis , Retrospective Studies , Skin Neoplasms , Smoking Cessation , Methods , Tobacco Use Disorder , Therapeutics , Treatment OutcomeABSTRACT
Background & objectives: Smokeless tobacco (SLT) consumption is a global health issue with about 350 million users and numerous adverse health consequences like oral cancer and myocardial disorders. Hence, cessation of SLT use is as essential as smoking cessation. An update on the available literature on SLT cessation intervention studies is provided here. Methods: Through an extensive literature search on SLT cessation intervention studies, using keywords such as smokeless tobacco, cessation, interventions, quitlines, brief advice, nicotine replacement therapy, nicotine gum, nicotine lozenge, nicotine patch, bupropion, varenicline, mHealth, etc., 59 eligible studies were selected. Furthermore, efficacy of the interventions was assessed from the reported risk ratios (RRs) [confidence intervals (CIs)] and quit rates. Results: Studies were conducted in Scandinavia, India, United Kingdom, Pakistan and the United States of America, with variable follow up periods of one month to 10 years. Behavioural interventions alone showed high efficacy in SLT cessation; most studies were conducted among adults and showed positive effects, i.e. RR [CI] 0.87 [0.7, 1.09] to 3.84 [2.33, 6.33], quit rate between 9-51.5 per cent, at six months. Regular telephone support/quitlines also proved beneficial. Among pharmacological modalities, nicotine lozenges and varenicline proved efficacious in SLT cessation. Interpretation & conclusions: Globally, there is limited information available on SLT cessation intervention trials, research on which must be encouraged, especially in the low-resource, high SLT burden countries; behavioural interventions are most suitable for such settings. Appropriate training/sensitization of healthcare professionals, and school-based SLT use prevention and cessation programmes need to be encouraged.
ABSTRACT
OBJECTIVE: Seoul City has implemented the Safe Pharmacy in 2013. This study aimed to ascertain the success factors of the smoking cessation service of the Safe Pharmacy. METHODS: The data for the smoking cessation registration cards were obtained from the pharmacies which participated in 2014 Safe Pharmacy. The sample included 289 smokers in 6 districts who participated at least one sessions of smoking cessation service. the service included both behavioral intervention and nicotine replacement therapy. In order to identify the effectiveness of the smoking cessation service, logistic regression analysis was used. The dependent variable was the success of quitting smoking at the 4th week. The independent variables included age, sex, employment, chronic disease, district, smoking amount, registration path, supporters for quitting smoking and number of service sessions. RESULTS: Fifty eight point eight percent of the sample successfully quit smoking at the 4th week. Unemployment, higher smoking amount, and less service sessions were negatively related to the success of quitting smoking. There were differences in the success rate across districts. Age, sex, chronic disease, registration path, and anti-smoking supporters were not related to the success rate. CONCLUSION: Pharmacy can be an effective community resource for smoking cessation. Factors that could increase the effectiveness of smoking cessation service of the Safe Pharmacy and possible ways to enhance the participation of pharmacies in smoking cessation services were also discussed.
Subject(s)
Chronic Disease , Employment , Logistic Models , Nicotine , Pharmaceutical Services , Pharmacies , Pharmacy , Seoul , Smoke , Smoking Cessation , Smoking , UnemploymentABSTRACT
El objetivo de este estudio exploratorio fue obtener información sobre la aceptabilidad en el uso de incentivos y de terapia de reemplazo nicotínico (TRN) como estrategia para apoyar la cesación tabáquica en mujeres que continúan fumando durante el embarazo. Se implementó un estudio descriptivo de corte transversal basado en un cuestionario administrado durante la internación hospitalaria en el posparto por encuestadoras entrenadas. Tres cuartos de las mujeres respondió que participarían en un estudio para probar la efectividad de los parches o chicles para dejar de fumar durante el embarazo y casi la mitad manifestó que sería de utilidad recibir una recompensa como incentivo para dejar de fumar durante el embazo.
The purpose of this exploratory study was to obtain information regarding acceptably to use incentives and Nicotine replacement therapy (NRT) as a smoking cessation strategy for women who continue smoking during pregnancy. A descriptive cross sectional study was implemented based on a questionnaire during hospital stay after delivering which was administered by trained data collector. Three quarter of women declared that they would participate in a study designed to test the effectiveness of the patches and gum to quit smoking, and almost half of the women declared that receiving a reward as an incentive to quit smoking, would be useful.
ABSTRACT
Introduction: Tobacco dependence is classified as a disease by the International Classification of Diseases (ICD-10), but, medical and dental professionals have neither seriously taken this fact nor made any serious attempt to tackle this disease. Apart from supporting wider tobacco control measures, oral health professionals can help patients to stop using tobacco. This may be the single most important service dentists can provide for their patients overall health. Objective:This review is prepared with the object to help both clinicians and oral health professionals to scale up their involvement in tobacco control activities, including advocacy and smoking cessation programs. Literature review:Studies have shown that 70% smokers indicate that they want to quit, but a meagre 2% succeed. The dental practice setting provides a unique opportunity to assist tobacco users in achieving tobacco abstinence. Still, More than 40% of dentists do not routinely ask about tobacco use and 60% do not routinely advise tobacco users to quit, while 61.5% of dentists believe their patients do not expect tobacco cessation services. Conclusion: Interventions by dentist has been found to be effective in helping people to quit tobacco consumption. A step-wise approach and patience must be adopted while dealing with such patients.
ABSTRACT
Background: Tobacco use contributes significantly to the diseases burden in India. Very few tobacco users spontaneously quit. Therefore, beginning 2002, a network of 19 tobacco cessation clinics (TCCs) was set up over a period of time to study the feasibility of establishing tobacco cessation services. Methods: Review of the process and operational aspects of setting up TCCs was carried out by evaluation of the records of TCCs in India. Baseline and follow-up information was recorded on a pre-designed form. Results: During a five-year period, 34 741 subjects attended the TCCs. Baseline information was recorded in 23 320 cases. The clients were predominantly (92.5%) above 20 years, married (74.1%) and males (92.2%). All of them received simple tips for quitting tobacco; 68.9% received behavioural counselling for relapse prevention and 31% were prescribed adjunct medication. At six-week follow-up, 3255 (14%) of the tobacco users had quit and 5187 (22%) had reduced tobacco use by more than 50%. Data for three, three-monthly follow-ups was available for 12 813 patients. In this group, 26% had either quit or significantly reduced tobacco use at first follow-up (three-months), 21% at the second (six-months) and 18% at the third follow-up (nine-months) had done so. Conclusions: It is feasible to set up effective tobacco cessation clinics in developing countries. Integration of these services into the health care delivery system still remains a challenge.
ABSTRACT
It was not above two or three decades from the changes began that regarding nicotine dependence as a kind of addictive disorder and a therapeutic target. Despite the short period of history, lots of medications were developed and showing significant clinical outcomes. In this review, we introduce the both of medications available at this time and in the status of developing for nicotine dependence. The clinical efficacies, practical ways of prescription, and common adverse events of the medications currently available are described through the survey of literatures. The novel medications in the process of developing are arranged by the proposed mechanism of action and summarized the phases of clinical trials at present. Among the diverse pharmacological tools now available, nicotine replacement and bupropion could be the first-line recommendation drugs and nortriptyline and clonidine could be the second-line recommendation drugs. Other medications like several antidepressants (e.g., moclobemide), buspirone, and naltrexone may be helpful in some specific population. Most of medications currently available have uncertainties in the aspects of their mechanisms of action except nicotine replacement materials; however, medications in developing have clearer neurobiological basis in their applications. Therefore, we can expect higher treatment outcomes by new products. Additionally, introduction of nicotine vaccines for high-risk group is drawing near. It could be possible for the individualizing for strategies of smoking cessation according to the patients' specific situation in a future.